Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2024.02.05
Z6尊龙:第六届监事会第五次聚会决议通告
2024.02.05
Z6尊龙:第六届董事会第八次聚会决议通告
2024.02.05
Z6尊龙:关于深圳证监局对公司接纳责令纠正步伐决议的整改报告
2024.01.31
Z6尊龙:关于对深圳证券生意所问询函回复的通告
2024.01.31
Z6尊龙:关于启动自力第三方视察的通告
2024.01.31
Z6尊龙:关于2023年度拟计提存货减价准备的提醒性通告
2024.01.31
Z6尊龙:2023年年度业绩预告
2024.01.16
Z6尊龙:关于收到深圳证监局羁系关注函的通告
2024.01.15
Z6尊龙:关于子公司主要事项的通告
2024.01.10
Z6尊龙:2024年第一次暂时股东大会决议通告
第一页
上一页
1
2
3
4
5
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】